ATE458501T1 - Enzym-prodrug-therapie für die reparatur einer gelenkprothese - Google Patents
Enzym-prodrug-therapie für die reparatur einer gelenkprotheseInfo
- Publication number
- ATE458501T1 ATE458501T1 AT05717867T AT05717867T ATE458501T1 AT E458501 T1 ATE458501 T1 AT E458501T1 AT 05717867 T AT05717867 T AT 05717867T AT 05717867 T AT05717867 T AT 05717867T AT E458501 T1 ATE458501 T1 AT E458501T1
- Authority
- AT
- Austria
- Prior art keywords
- prostheses
- repair
- joint prosthesis
- prodrug therapy
- enzyme prodrug
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
- A61K47/67—Enzyme prodrug therapy, e.g. gene directed enzyme drug therapy [GDEPT] or VDEPT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Prostheses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0405103A GB0405103D0 (en) | 2004-03-06 | 2004-03-06 | Enzyme-prodrug therapy for prosthetic joint repair |
US56306704P | 2004-04-16 | 2004-04-16 | |
GB0420217A GB0420217D0 (en) | 2004-09-11 | 2004-09-11 | Enzyme-prodrug therapy for prosthetic joint repair |
US61330504P | 2004-09-27 | 2004-09-27 | |
PCT/GB2005/000789 WO2005084713A2 (en) | 2004-03-06 | 2005-03-04 | Enzyme-prodrug therapy for prosthetic joint repair |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458501T1 true ATE458501T1 (de) | 2010-03-15 |
Family
ID=34923330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05717867T ATE458501T1 (de) | 2004-03-06 | 2005-03-04 | Enzym-prodrug-therapie für die reparatur einer gelenkprothese |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1725267B1 (de) |
JP (1) | JP5003480B2 (de) |
AT (1) | ATE458501T1 (de) |
CA (1) | CA2556790A1 (de) |
DE (1) | DE602005019542D1 (de) |
ES (1) | ES2341555T3 (de) |
WO (1) | WO2005084713A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11219696B2 (en) | 2008-12-19 | 2022-01-11 | Nationwide Children's Hospital | Delivery of polynucleotides using recombinant AAV9 |
US20130039888A1 (en) | 2011-06-08 | 2013-02-14 | Nationwide Children's Hospital Inc. | Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
DK2879719T3 (en) | 2012-08-01 | 2018-09-03 | Nationwide Childrens Hospital | INTRATEKAL ADMINISTRATION OF RECOMBINANT ADENOASSOCATED VIRUSES |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1141318B1 (de) | 1999-01-04 | 2006-07-05 | Innovata PLC | P450 / acetaminophen gdept zur krebsbehandlung |
GB9900009D0 (en) * | 1999-01-04 | 1999-02-24 | Ml Lab Plc | Gene therapy |
JP2004500097A (ja) * | 2000-03-02 | 2004-01-08 | エムエル ラボラトリーズ ピーエルシー | Tcf応答性エレメント |
-
2005
- 2005-03-04 ES ES05717867T patent/ES2341555T3/es active Active
- 2005-03-04 AT AT05717867T patent/ATE458501T1/de not_active IP Right Cessation
- 2005-03-04 DE DE602005019542T patent/DE602005019542D1/de active Active
- 2005-03-04 JP JP2007501343A patent/JP5003480B2/ja not_active Expired - Fee Related
- 2005-03-04 CA CA002556790A patent/CA2556790A1/en not_active Abandoned
- 2005-03-04 EP EP05717867A patent/EP1725267B1/de not_active Not-in-force
- 2005-03-04 WO PCT/GB2005/000789 patent/WO2005084713A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP1725267B1 (de) | 2010-02-24 |
ES2341555T3 (es) | 2010-06-22 |
CA2556790A1 (en) | 2005-09-15 |
WO2005084713A3 (en) | 2005-10-20 |
WO2005084713A2 (en) | 2005-09-15 |
DE602005019542D1 (de) | 2010-04-08 |
EP1725267A2 (de) | 2006-11-29 |
JP5003480B2 (ja) | 2012-08-15 |
JP2007527427A (ja) | 2007-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008090468A3 (en) | An implant and a method for partial replacement of joint surfaces | |
IL205114A0 (en) | Method and system for plicating tissue in a minimally invasive medical procedure for the treatment of mitral valve regurgitation | |
ATE551035T1 (de) | Implantat zur behandlung des obstruktiven schlafapnoesyndroms | |
ATE466532T1 (de) | Flexibles und verlängertes kettenimplantat | |
UA99167C2 (ru) | Лечение дегенерации межреберных дисков с использованием клеток, полученных из ткани пуповины человека | |
WO2007133553A3 (en) | Artificial spinal disc implant | |
WO2007067909A3 (en) | Instruments and techniques for delivering non-rigid implant members in surgical procedures | |
WO2006060416A3 (en) | Implants and delivery system for treating defects in articulating surfaces | |
WO2007038188A3 (en) | Joint prosthesis and method of implanting same | |
ATE392869T1 (de) | Artikulierbares implantatsystem | |
WO2006096793A3 (en) | Medical implants | |
WO2009111624A3 (en) | Implants and methods of use | |
WO2007076178A3 (en) | Modular dental implants with extensions | |
ATE472978T1 (de) | Bandscheibenprothese zur wirbelsäulenstabilisierung | |
WO2005089411A3 (en) | Tissue products from animals lacking functional alpha 1,3 galactosyl transferase | |
WO2009022911A3 (en) | Prosthesis comprising an anti-micromotion bone-interfacing surface and method for the manufacture thereof | |
MX2009007826A (es) | Cepillos de dientes. | |
EP1959869A4 (de) | Situsspezifische minimal invasive gelenkimplantate | |
HK1079075A1 (en) | Minimally invasive instruments and methods for inserting implants | |
WO2012174383A3 (en) | Heart valve prosthesis anchoring devices and methods | |
WO2009059032A3 (en) | Uses and isolation of very small embryonic-like (vsel) stem cells | |
ATE514396T1 (de) | Implantat zur fixierung eines knochentransplantats innerhalb eines gelenks um die arthrodese des gelenks sicherzustellen | |
WO2005000159A3 (en) | Tissue integration design for seamless implant fixation | |
ATE438348T1 (de) | Zwischenlaminae wirbelsäulenprothese | |
WO2007089858A3 (en) | Spinal disc prosthesis apparatus and placement method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |